A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China
Conditions: Infertility, Female Interventions: Drug: FE 999049; Drug: GONAL-F Sponsors: Ferring Pharmaceuticals Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 18, 2023 Category: Research Source Type: clinical trials
PRO1107 in Patients With Advanced Solid Tumors
Conditions: Endometrial Cancer; Ovarian Cancer; Triple Negative Breast Cancer; GastroEsophageal Cancer; Non-small Cell Lung Cancer; Urothelial Carcinoma Interventions: Drug: PRO1107 Sponsors: ProfoundBio US Co. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
RC88 in Platinum-Resistant Recurrent Epithelial Ovarian Cancer, Fallopian Tube Cancer, and Primary Peritoneal Cancer
Conditions: Primary Peritoneal Cancer; Fallopian Tube; Epithelial Ovarian Interventions: Drug: RC88 Sponsors: RemeGen Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 15, 2023 Category: Research Source Type: clinical trials
Insulin Sensitizers Role in Control of PCOS Vicious Cycle.
Conditions: PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries Interventions: Drug: Metformin Hydrochloride; Drug: MI/DCI combination in 40:1 ratio; Drug: Combination of Metformin hydrochloride and MI/DCI Sponsors: Zagazig University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 14, 2023 Category: Research Source Type: clinical trials
Trial of Ovarian Vein and Pelvic Vein Embolization in Women With Chronic Pelvic Pain and Pelvic Varices
Conditions: Chronic Pelvic Pain Syndrome; Pelvic Pain; Pelvic Varices; Pelvic Congestive Syndrome; Pelvic Pain Syndrome Interventions: Diagnostic Test: Transcatheter Venography; Procedure: Bilateral ovarian vein embolization Sponsors: Weill Medical College of Cornell University; Society of Interventional Radiology Foundation; Foundation for Venous and Lymphatic Medicine; VIVA Physicians; Penumbra Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
Study to Test the Drug Darolutamide Along With the Drugs Leuprolide Acetate and Exemestane in Patients With Recurrent Ovarian Granulosa Cell Tumors
Conditions: Adult Ovarian Granulosa Cell Tumor Interventions: Procedure: Biospecimen Collection; Procedure: Chest Radiography; Procedure: Computed Tomography; Drug: Darolutamide; Drug: Exemestane; Drug: Leuprolide Acetate; Procedure: Magnetic Resonance Imaging; Procedure: Positron Emission Tomography Sponsors: National Cancer Institute (NCI); NRG Oncology Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
The Synbiotics Effects in Polycystic Ovary Syndrome: A Randomized Controlled Trial
Conditions: PCOS- Polycystic Ovary Syndrome Interventions: Dietary Supplement: synbiotics; Combination Product: placebo Sponsors: Maharaj Nakorn Chiang Mai Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 13, 2023 Category: Research Source Type: clinical trials
Polycystic Ovary Syndrome, Mitochondrial Dysfunction, Obesity, Insulin Resistance Infertility (POMODORI) Cohort
Conditions: Infertility, Female; Polycystic Ovary Syndrome; Insulin Resistance; Primary Ovarian Insufficiency; Mitochondrial Alteration; Obesity Sponsors: Semmelweis University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 12, 2023 Category: Research Source Type: clinical trials
Pivotal Influence of Obesity on Body Composition and Ovarian Doppler in Different Polycystic Ovarian Syndrome Phenotypes
Conditions: Polycystic Ovary Syndrome; Obesity Interventions: Other: Evaluation of Phenotypes of PCOS, Anthropometric parameters, Body composition parameters, and Ovarian Doppler parameters Sponsors: Cairo University; Helwan University; National Research Centre, Egypt Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 11, 2023 Category: Research Source Type: clinical trials
ZEN003694 Combined With Niraparib in Patients With Metastatic or Recurrent Solid Tumors
Conditions: Ovarian Cancer; Recurrent Solid Tumors Interventions: Drug: ZEN003694; Drug: Niraparib Sponsors: Haider Mahdi; GlaxoSmithKline; Zenith Epigenetics Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials
Pilot Study of the eHealth Application " Cancer Patients Better Life Experience " (CAPABLE) - Italy
Conditions: Renal Cell Carcinoma Metastatic; Breast Cancer; Head and Neck Cancer; Thyroid Cancer; Ovary Cancer; Lung Cancer; Stomach Cancer Interventions: Device: CAPABLE cohort Sponsors: Istituti Clinici Scientifici Maugeri SpA; University of Pavia; Policlinico di Bari Ospedale Giovanni Paolo XXIII; Biomeris srl; The Netherlands Cancer Institute NKI; University of Haifa; Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA); IBM Research; Bitsens JSC; Pozna ń University of Technology; Deontics LTD; Associazione Italiana Malati di Cancro AIMAC; Universidad Politécnica de Madrid. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
Fluzoparib With or Without Apatinib in Platinum-sensitive Relapsed Ovarian Cancer Previously Treated With PARPi
Conditions: Ovarian Cancer; High Grade Serous Adenocarcinoma of Ovary; Primary Peritoneal Carcinoma; Fallopian Tube Cancer Interventions: Drug: Fluzoparib; Drug: Fluzoparib+Apatinib Sponsors: Guangxi Medical University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
A Study of Raludotatug Deruxtecan (R-DXd) in Subjects With Platinum-resistant, High Grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Conditions: Solid Cancer Interventions: Drug: R-DXd; Drug: Gemcitabine; Drug: Paclitaxel; Drug: Topotecan; Drug: PLD Sponsors: Daiichi Sankyo, Inc.; Merck Sharp& Dohme LLC Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 7, 2023 Category: Research Source Type: clinical trials
A Single Group Study to Evaluate the Effects of a Myo-Inositol and D-Chiro Inositol Supplement on Symptoms Associated With Polycystic Ovary Syndrome and Hormone Imbalance
Conditions: Polycystic Ovary Syndrome; Hormone Imbalance Interventions: Dietary Supplement: Optify Myo Inositol and D-Chiro Inositol Plus Folate and Vitamin D supplement Sponsors: Optify; Citruslabs Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2023 Category: Research Source Type: clinical trials
Exogenous Ketone Supplementation in Females With Polycystic Ovary Syndrome
Conditions: PCOS Interventions: Dietary Supplement: Ketone; Dietary Supplement: Water Sponsors: McGill University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials
